Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With
an increasing number of the elderly population, and early cancer screening and treatment …

Background For decades, conflicting results were published regarding the increased risk of
Prostate cancer (PCa) among calcium channel blocker (CCB) users. Objective We aimed to …

Prostate cancer is often treated by perturbing androgen receptor signalling. CACNA1D,
encoding CaV1. 3 ion channels is upregulated in prostate cancer. Here we show how …

Cancer remains a prominent cause to life expectancy, and targeted cancer therapy stands
as a pivotal approach in contemporary therapy. Calcium (Ca2+) signalling plays a …

Background Hypertension is associated with the risk of prostate cancer (PCa) and its
progression, however, it remains unclear whether antihypertensive medicines alter PCa risk …

Purpose Although calcium channel blockers (CCBs) are now commonly prescribed to treat
hypertension as a first-line drug therapy, their impact on prostate cancer (PCa) is unclear …

Prostate cancer (PCa) is an age-related, heterogeneous disease and the most common
cancer in UK males. Early localised PCa is commonly treated with radiotherapy or surgery …

Сердечно-сосудистые заболевания (ССЗ) и онкологические болезни являются
лидирующими причинами смерти в мире. Широкое применение сердечно-сосудистых …

Dear editor, Calcium channel blockers are commonly prescribed to treat hypertension. The
association between calcium channel blockers use and cancer risk has been extensively …